Treatment for Chlamydia trachomatis
The recommended first-line treatment for uncomplicated chlamydial infection is either azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days, both with efficacy rates of approximately 97-98%. 1, 2, 3
First-Line Treatment Options
- Azithromycin 1 g orally in a single dose has advantages including directly observed therapy and better compliance, making it particularly useful when adherence to multi-day regimens is questionable 1, 3
- Doxycycline 100 mg orally twice daily for 7 days has advantages including lower cost and extensive clinical experience 1, 3
- Both medications are equally efficacious for genital chlamydial infections, with meta-analyses showing no statistically significant difference in microbial cure rates (97% for azithromycin vs 98% for doxycycline) 4
Alternative Treatment Options
- Erythromycin base 500 mg orally four times a day for 7 days 5, 1
- Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 5, 1
- Ofloxacin 300 mg orally twice a day for 7 days 5, 1
- Levofloxacin 500 mg orally once daily for 7 days 5, 1
Implementation Best Practices
- Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance 5, 1
- Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 5, 3
- Patients should also abstain from sexual intercourse until all sex partners are treated to minimize risk of reinfection 5, 1
Special Populations
Pregnancy
- Azithromycin 1 g orally in a single dose is recommended during pregnancy 2
- Amoxicillin 500 mg orally three times a day for 7 days is an alternative option during pregnancy 1, 2
- Doxycycline and fluoroquinolones (ofloxacin, levofloxacin) are contraindicated during pregnancy 2
Coinfection with Gonorrhea
- Patients with gonorrhea often have co-infection with chlamydia (20-40%), and when treating gonorrhea, treatment for both infections should be provided if chlamydial infection has not been excluded 3
Partner Management
- All sex partners from the previous 60 days should be evaluated, tested, and treated 1, 3
- If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1
Follow-Up Recommendations
- Test-of-cure is not routinely recommended after completing treatment with recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1, 3
- Consider retesting women approximately 3 months after treatment due to high risk of reinfection 1, 3
Clinical Considerations and Pitfalls
- Gastrointestinal side effects are common with both treatments (25% for azithromycin vs 23% for doxycycline) but are generally mild to moderate 4
- Erythromycin often causes gastrointestinal side effects that lead to poor compliance, making it a less desirable alternative 1, 3
- Treatment failure is uncommon with recommended regimens, with failure rates of 0-3% for males and 0-8% for females 1
- When selecting between azithromycin and doxycycline, consider patient compliance factors and cost - azithromycin is preferred when compliance is a concern, while doxycycline is generally less expensive 1, 6